OpGen, Inc. (NASDAQ:OPGN – Get Free Report)’s stock price crossed above its fifty day moving average during trading on Wednesday . The stock has a fifty day moving average of $1.02 and traded as high as $1.37. OpGen shares last traded at $1.37, with a volume of 3,716 shares traded.
Analyst Ratings Changes
Separately, StockNews.com assumed coverage on OpGen in a research note on Thursday. They set a “sell” rating on the stock.
Check Out Our Latest Stock Analysis on OpGen
OpGen Stock Up 14.2 %
About OpGen
OpGen, Inc, a precision medicine company, engages in developing and commercializing molecular microbiology solutions in the United States and internationally. Its product portfolio includes Acuitas AMR Gene Panel, an in vitro diagnostic (IVD) test for the detection and identification of various bacterial nucleic acids and genetic determinants of antimicrobial resistance (AMR) from bacterial colonies isolated from any specimen, as well as Curetis CE-IVD-marked polymerase chain reaction-based SARS-CoV-2 test kits.
Read More
- Five stocks we like better than OpGen
- How to Use the MarketBeat Stock Screener
- 3 Reasons Micron Stock Is Deeply Undervalued Right Now
- Financial Services Stocks Investing
- Inflation Persists, But So Do Stock Opportunities: Rally On
- 3 REITs to Buy and Hold for the Long Term
- Energy Transfer Fuels the Cloud: A Natural Gas Power Play
Receive News & Ratings for OpGen Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for OpGen and related companies with MarketBeat.com's FREE daily email newsletter.
